EligibleTrials

Clinical trials recruiting for Axial Spondyloarthritis

6
Recruiting trials
18
US states with sites
12
Countries
33%
Accept healthy volunteers

Phase breakdown

Phase 1 2Phase 4 1Not applicable 3

Drugs and treatments being studied

InterventionTrials
Bimekizumab1
Bimekizumab regimen 1 iv1
Bimekizumab regimen 2 iv1
Bimekizumab regimen 3 sc1
Dengue 1,2,3,4 (attenuated) vaccine1

Where trials are recruiting (top US states)

StateRecruiting trials
California2
Florida2
Arizona1
Colorado1
Illinois1
Massachusetts1
Michigan1
New Jersey1
New Mexico1
North Carolina1
Ohio1
Pennsylvania1

Top cities

South Miami, Florida 2Albuquerque, New Mexico 1Apple Valley, California 1Baytown, Texas 1Beckley, West Virginia 1Bellevue, Washington 1Boston, Massachusetts 1Chapel Hill, North Carolina 1Chicago, Illinois 1Colleyville, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Axial Spondyloarthritis often also study these conditions. Each links to its own recruiting-trial list.

Psoriasis 233Psoriatic arthritis 45Rheumatoid arthritis 314Takayasu Arteritis 3Systemic Sclerosis (SSc) 28Systemic lupus erythematosus 119Sarcopenia 45Psoriatic Arthritis (PsA) 18Osteoporosis 132Moderate to Severe Plaque Psoriasis 5

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Axial Spondyloarthritis trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.